APA (7th ed.) Citation

C, D., F, H., C, L., D, G., CF, S., S, K., . . . G, P. (2026). Is Genetic Testing of HER2-Negative Metastatic Breast Cancer Patients Implemented into Clinical Practice? A Retrospective Analysis. Journal of clinical medicine, 15(9), . https://doi.org/10.3390/jcm15093433

Chicago Style (17th ed.) Citation

C, Deutschmann, Heinzl F, Leser C, Gschwantler-Kaulich D, Singer CF, Kostic S, Golescu A, and Pfeiler G. "Is Genetic Testing of HER2-Negative Metastatic Breast Cancer Patients Implemented into Clinical Practice? A Retrospective Analysis." Journal of Clinical Medicine 15, no. 9 (2026). https://doi.org/10.3390/jcm15093433.

MLA (9th ed.) Citation

C, Deutschmann, et al. "Is Genetic Testing of HER2-Negative Metastatic Breast Cancer Patients Implemented into Clinical Practice? A Retrospective Analysis." Journal of Clinical Medicine, vol. 15, no. 9, 2026, https://doi.org/10.3390/jcm15093433.